SMN2 and proximal spinal muscular atrophy: According to the authors of this article, more than 70% of SMA patients with two SMN2 copies can achieve independent ambulation with immediate initiation of therapy, but they simultaneously suggested the possibility of less favorable outcomes in the remainder of patients [46].